Accessibility Menu
 
VolitionRx logo

VolitionRx

(NYSEMKT) VNRX

Current Price$0.14
Market Cap$22.82M
Since IPO (2011)-95%
5 Year-96%
1 Year-70%
1 Month-28%

VolitionRx Financials at a Glance

Market Cap

$22.82M

Revenue (TTM)

$1.73M

Net Income (TTM)

$23.36M

EPS (TTM)

$-0.22

P/E Ratio

-0.66

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Price

$0.14

Volume

6,340

Open

$0.14

Previous Close

$0.14

Daily Range

$0.14 - $0.14

52-Week Range

$0.14 - $0.94

VNRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About VolitionRx

Industry

Healthcare Equipment and Supplies

Employees

75

CEO

Cameron John Reynolds, MBA

Headquarters

Henderson, TX 78738, US

VNRX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-13%

Net Income Margin

-14%

Return on Equity

0%

Return on Capital

4%

Return on Assets

-3%

Earnings Yield

-1.52%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$22.82M

Shares Outstanding

158.48M

Volume

6.34K

Short Interest

0.00%

Avg. Volume

11.20M

Financials (TTM)

Gross Profit

$1.73M

Operating Income

$21.22M

EBITDA

$19.80M

Operating Cash Flow

$19.68M

Capital Expenditure

$89.56K

Free Cash Flow

$19.77M

Cash & ST Invst.

$1.12M

Total Debt

$11.46M

VolitionRx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$447.03K

+133.2%

Gross Profit

$447.03K

+133.2%

Gross Margin

100.00%

N/A

Market Cap

$22.82M

N/A

Market Cap/Employee

$268.49K

N/A

Employees

85

N/A

Net Income

$6.27M

-8.2%

EBITDA

$4.95M

+8.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$10.35M

-304.8%

Accounts Receivable

$317.81K

+187.4%

Inventory

$0.00

N/A

Long Term Debt

$7.85M

+67.3%

Short Term Debt

$3.61M

+220.1%

Return on Assets

-3.38%

N/A

Return on Invested Capital

4.06%

N/A

Free Cash Flow

$5.50M

+2.3%

Operating Cash Flow

$5.49M

-1.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SKYESkye Bioscience, Inc.
$0.92+2.04%
NOTVInotiv, Inc.
$0.28-5.98%
WGRXWellgistics Health, Inc.
$0.13-4.64%
INMBINmune Bio, Inc.
$1.42+2.54%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.03+0.00%
NOKNokia
$10.45+0.01%
POETPoet Technologies
$15.12+0.29%
TQQQProShares Trust - ProShares UltraPro Qqq
$62.31+0.05%

Questions About VNRX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.